Klimakterium der Frau

  • B. Runnebaum
  • T. Rabe
  • T. v. Holst
  • C. Wüster

Zusammenfassung

Das Klimakterium stellt im Leben einer Frau eine Übergangsphase dar zwischen dem Erlöschen der Fortpflanzungsfähigkeit und dem Beginn der späten Postmenopause. Es umfaßt nach neueren Erkenntnissen etwa den Lebensabschnitt zwischen dem 47. und 55. Lebensjahr. Während dieser Zeit erlebt die Frau die letzte von den Eierstöcken gesteuerte Menstruationsblutung, die sog. Menopause. In Mitteleuropa tritt die Menopause durchschnittlich mit 51 Jahren ein. Ein Zeitraum von 5 Jahren vor dieser Menopause wird als Prämenopause bezeichnet, der Zeitraum ab 1 Jahr nach der Menopause heißt Postmenopause. Die Perimenopause stellt die Übergangsphase zwischen Prämenopause und Postmenopause dar, d. h. 2 Jahre vor der Menopause bis 1 Jahr danach.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aertgeerts J (1974). Wirkung oraler Östrogene auf die Haut der Frau in der Postmenopause und nach Kontrazeption. Ther Gegenw 113: 1739PubMedGoogle Scholar
  2. Alffram PA, Bauer GCH (1962) Epidemiology of fractures of the forearm. J Bone Joint Surg 44-A: 105–114Google Scholar
  3. Alhava EM, Puttinen J (1973) Fractures of the upper end of the femur as an index of senile osteoporosis in Finland. Ann Clin Res 5: 398–403PubMedGoogle Scholar
  4. Andersch G, Hahn L (1985) Progesterone treatment of premenopausal tension — a double blind study. J Psychosom Res 29: 489PubMedCrossRefGoogle Scholar
  5. Andersch B, Wendestam C, Hahn L, Ohman R (1986) Premenstrual complaints. I. prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet Gynaecol 5: 39–49Google Scholar
  6. Anderson I, Janzon L, Sigfusson BF (1985) Mammographie breast cancer screening — a randomized trial in Malmö, Sweden. Maturitas 7:21 — 29Google Scholar
  7. Anderson E, Hamburger S, Liu JH, Rebar RW (1987) Characteristics of menopausal women seeking assistance. Am J Ob-stet Gynecol 156: 428–433Google Scholar
  8. Arafat ES, Hargrove JT, Maxson WS, Desiderio DM, Wentz AC, Anderson RN (1988) Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am J Obstet Gynecol 159:1203 —1209Google Scholar
  9. Aylward M (1976) Estrogens, plasma tryptophan levels in peri-menopausal patients. In: Campbell S (ed) The managment of the menopause and postmenopausal years. MTP Press, Lancaster, 135CrossRefGoogle Scholar
  10. Baker TG (1963) A quantitative and cytological study of germ cells in human ovaries. Proc Soc 158: 417–433CrossRefGoogle Scholar
  11. Ballinger CB (1975) Psychiatric morbidity and the menopause: Screening of general population sample. Br Med J 3: 344–346PubMedCrossRefGoogle Scholar
  12. Banzer D (1979) Quantitative Skelettdiagnostik bei demineralisierenden Osteopathien. Röntgenpraxis 32: 158–166Google Scholar
  13. Basdevant A, de Lignieres B (1980) Treatment of menopause by topical administration of estradiol. In: Mauvais-Jarvis P, Vickers CFH, Wepierre J (eds) Percutaneous absorption of steroids. Academic Press, London, p 249Google Scholar
  14. Batrinos ML, Panitsa-Faflia C, Pitoulis S et al (1979) The clinical features of the menopause and its relation to the length of pregnancies and lactation. Maturitas 1: 26–268Google Scholar
  15. Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C (1989) The risk of breast cancer after estrogen and estrogenprogestin replacement. N Engl J Med 321: 293–297PubMedCrossRefGoogle Scholar
  16. Blair SN, Goodyear NN, Gibbons LW, Cooper KH (1984) Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252: 487–490PubMedCrossRefGoogle Scholar
  17. Block E (1952) Quantitative morphological investigations of the follicular system in women: variation at different ages. Acta Anat (Basel) 14:108 —123Google Scholar
  18. Brincat M, Moniz CF, Studd JWW, Darby AJ, Magos A, Cooper D (1983) Sex hormones and skin collagen content in postmenopausal women. Br Med J 287: 1337–1338CrossRefGoogle Scholar
  19. Bush TL (1991) Epidemiology of cardiovascular disease in women. In: Redmond GP (ed) Lipids and women’s health. Springer, New York Berlin Heidelberg TokyoGoogle Scholar
  20. Bush TL, Barret-Connor E, Cowan LD et al (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102–9PubMedCrossRefGoogle Scholar
  21. Butz S, Wüster C, Scheidt-Nave C, Götz M, Ziegler R (1993) Forearm BMD as measured by peripheral quantitative computed tomography (pQCT) in a German reference population. Osteoporosis Int 1993Google Scholar
  22. Caniggia A (1984) The hormonal form of Vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. J Endocrinol Invest 7/4:373 —378Google Scholar
  23. Cardozo L, Gibb DMF, Tuck SM, Thom MH, Studd JWW, Cooper DJ (1984). The effects of subcutaneous hormone implants during the climacteric. Maturitas 5: 177–184PubMedCrossRefGoogle Scholar
  24. Caudron J, Hendrickx B (1988) Comparison of two equine oestrogen-dydrogestrone regimens in the climacteric. Maturitas 10:133 —141Google Scholar
  25. Christensen MS. Hagen C. Christiansen C, Transböl I (1982) Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynaecologic and metabolic actions. Am J Obstet Gynaecol 144:873 —879Google Scholar
  26. Christenson, CV, Gagnon JH (1965) Sexual behaviour in a group of older women. J Gerontol 20: 351–356Google Scholar
  27. Christiansen C, Rus BJ (1990) 17ß-Estradiol and continous norethisterone: a unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 71: 836–841Google Scholar
  28. Christiansen C, Christiansen MS, Transböl I (1981) Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet I: 459–461Google Scholar
  29. Clarkson T (1992) Sex steroids and atherosclerosis in animal models. „Safty aspects of hormone replacement therapy“. International Symposium, 4–5 September, wells Medical Limited Copenhagen, pp 101–108Google Scholar
  30. Coopen A, Wood K (1982) 5-Hydroxytryptamine in the pathogenesis of affective disorders. In: Ho BT, Schoolar JC, Us-din E (eds) Serotonin in biological psychiatry. Raven, New York, pp 249–259Google Scholar
  31. Coulam CB (1981) Age, estrogens, and the psyche. Clin Obstet Gynecol 24:219 —229Google Scholar
  32. Cummings S, Browner W, Grady D et al. (1990) Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry? (Editorial) Ann Intern Med 113: 565–567Google Scholar
  33. Curhan GC, Willett, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328: 833–838PubMedCrossRefGoogle Scholar
  34. Dambacher MA, Rüegsegger P (1985) Nichtinvasive Untersuchungsmethoden bei Osteoporosen. Ther Umsch 42: 339–350PubMedGoogle Scholar
  35. Dambacher MA, Rüegsegger P, Demarmels MA, Fischer JA (1986) Pathogenesis and treatment of osteoporosis. In: Vaganakis A, Soucacos P, Avramides A et al (eds) Osteoporosis. Social and clinical aspects. 2nd International Conference on Osteoporosis. Masson Italia Editori, Mailand, pp 175 —194Google Scholar
  36. Dambacher MA, pers. Mitteilung (1994)Google Scholar
  37. Dennerstein L, Wood C, Burrows GD (1977) Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 49:92— 96Google Scholar
  38. Dequeker J, Roh YS, Dessel D, van Gautama K, Burssens A (1973) Bone mineral estimation in vivo by photon absorptiometry. Influence of skeletal size and its value for detecting osteoporosis. J Belge Med Phys Rhum 28: 293Google Scholar
  39. Daring GK (1976) Klimakterische Beschwerden. Teil 1: Typische klimakterische Beschwerden. Fortschr Med 94:1058 —1061Google Scholar
  40. Dupont WD, Page DL, Roger LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63: 948–957PubMedCrossRefGoogle Scholar
  41. Edman LD (1983) The climacteric. In: Buchsbaum HJ (ed) The menopause. Springer, Berlin Heidelberg New York Tokyo, pp 77–84CrossRefGoogle Scholar
  42. Eggert-Kruse W, Runnebaum B, Kruse W (1990) Hormonprofile in der späten Postmenopause. In: Lauritzen C (Hrsg) Menopause, Hormonsubstitution heute 3. edition informed, München, S 18–25Google Scholar
  43. Eriksen EF, Colvard DS, Berg NJ et al. (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84— 86Google Scholar
  44. Ettinger B, Genant HK, Steiger P, Madvig P (1992) Low-doseage micronized 17ß-estradiol prevents bone loss in postmenopausal women. Am J Obstet Gynecol 166: 479–488PubMedGoogle Scholar
  45. Felsenberg D 1 991) Comparison of trabecular borie density at different anatomical sites: a prospective clinical study. (Vorgestellt bei der Jahrestagung der Radio! Soc North Am Chicago)Google Scholar
  46. Gambrell RD (1978) The prevention of endometrial cancer in postmenopausal women with progestogens. Maturitas 1: 107–112PubMedCrossRefGoogle Scholar
  47. Gambrell RD (1986a) Prevention of endometrial cancer with progestogens. Maturitas 8: 159–168PubMedCrossRefGoogle Scholar
  48. Gambrell RD (1986b) Role of progestrons in the prevention ob breast cancer. Maturitas 8: 169–176PubMedCrossRefGoogle Scholar
  49. Gambrell RD, Maier RC, Sanders BI (1983) Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 62:435 —443Google Scholar
  50. Glatzner CM, Bailey I, Hull MGR (1985) Effectiveness of vaginal administration of progesterone. Br J Obstet Gynaecol 92: 364CrossRefGoogle Scholar
  51. Goldfarb AF, Daly MJ, Lieberman D, Reed DM (1970) Round- table: sex and menopause. Med Aspects Hum Sex 64Google Scholar
  52. Gordan GS (1977) Postmenopausal osteoporosis, cause, prevention and treatment. In: Greenblatt RB, Studd J (eds) Clinics in obstetrics and gynaecology 4. Saunders, London, p 169Google Scholar
  53. Gordan GS (1984) Prevention of bone loss and fractures in women. Maturitas 6:225–242Google Scholar
  54. Gray LA, Christopherson WM, Hoover RN (1977) Estrogens and endometrial carcinoma. Obstet Gynecol 49: 385–389PubMedGoogle Scholar
  55. Greenblatt R (1979) An endocrinologist comments on hormones for sexual dysfunction. Female Patient 4: 43–46Google Scholar
  56. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Help WB, Sisom K, Chesnut CH (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33: 295–304PubMedCrossRefGoogle Scholar
  57. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA (1988) Postmenopausel use of estrogen and occlusion of coronary arteries. Am Heart J 115: 954–963PubMedCrossRefGoogle Scholar
  58. Hartge P, Hoover R, McGowan L, Lesher L, Norris HJ (1988) Menopause and ovarian cancer. Am J Epidemiol 127: 990 — 998Google Scholar
  59. Henderson BE, Ross RK, Paganini-Hill A, Mack TM (1986) Estrogen use and cardiovascular disease. Am J Obstet Gynecol 154: 1181–6PubMedGoogle Scholar
  60. Herrmann WM, Beach RC (1978) The psychotropic properties of estrogens. Pharmakopsychiatry 11: 164–176CrossRefGoogle Scholar
  61. Heuck F (1989) Qualitative und quantitative radiologische Analyse des Knochens. In: Dihlmann W, Frommhold W (Hrsg) Schinz — Radiologische Diagnostik in Klinik und Praxis, Bd 6 Thieme, Stuttgart, S 151–215Google Scholar
  62. Hillard TC, Whitehead MI (1991) Hormon-Substitutionstherapie — Wege der Verabreichung In: Medical Communications Services (Hrsg) Kardiovaskuläre Wirkungen einer Hormonsubstitutionstherapie. Proceedings Internationales Novo Nordisk Symposium Kopenhagen, Dänemark, 1.-2. Februar 1991Google Scholar
  63. von Holst T (1982) Hormonelle Diagnostik im Klimakterium der Frau. Habilitationsschrift, Ruprecht-Karls-Universitäts HeidelbergGoogle Scholar
  64. von Holst T (1989) Nebennierenrindenfunktion in der Postmenopause und im Senium. In: Lauritzen C (Hrsg) Menopause, Hormonsubstitution heute 2. edition informed, München, S9–15Google Scholar
  65. Horwitz RI, Stewart KR (1984) Effect of clinical features on the association of estrogens and breast cancer. Am J Med 76:192 —198Google Scholar
  66. Huber J (1991) Substitutionstherapie im Klimakterium: Soll bei hysterektomierten Frauen auf Progestogene verzichtet werden? Geburtshilfe Frauenheilkd 51: 257–261PubMedCrossRefGoogle Scholar
  67. Hunt K, Vessey M, McPherson K, Coleman M (1987) Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94: 620–635PubMedCrossRefGoogle Scholar
  68. Hunter MS (1990) Emotional well-being, sexual behaviour and hormone replacement therapy. Maturitas 12: 299–314PubMedCrossRefGoogle Scholar
  69. Husmann F (1993). Der vaso- und kardioprotektive Effekt der Östrogene. In: Schering AG, Pharma (Hrsg) Fachinformation zum Thema Klimakterium. Schering, BerlinGoogle Scholar
  70. Janich H (1993) Die Älterenanteile in den Bundesländern und in den Gebietstypen: regionale Unterschiede in der Betroffenheit der Älteren durch die Einrichtung von Landes-AOK’s. In: Verband der Kriegs- und Wehrdienstopfer, Behinderten und Renter Deutschland, Landesverband Bayern e.V. (Hrsg) Vdk-Forum in der Evangelischen Akademie Tutzing am 17./18. 2. 1993Google Scholar
  71. Judd HL (1976) Hormonal dynamics associated with the menopause. Clin Obstet Gynecol 19: 775–788PubMedCrossRefGoogle Scholar
  72. Kaiser R (1984) Duration of the climacteric syndrome in women treated by hormonal substitution and in controls. Maturitas 5: 207–213PubMedCrossRefGoogle Scholar
  73. Kalender WA (1991) Abschätzung der effektiven Dosis bei Knochenmineralmessungen mit Photonenabsorptiometrie und Computertomographie. ROFO 155 /2: 149–154PubMedCrossRefGoogle Scholar
  74. Kampke D, Walcher W (1982) Physik für Mediziner. Teubner, StuttgartCrossRefGoogle Scholar
  75. Kannei WB (1987) Metabolic risk factors for coronary artery disease in women: perspective from the Framingham study. Am Heart J 114: 413–9CrossRefGoogle Scholar
  76. Kannei WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85: 447–452Google Scholar
  77. van Keep PA, Kellerhals J (1974) Die älter werdende Frau. Therapiewoche 45:5170 — 5194Google Scholar
  78. Kendell RE, Wainwright S, Hailey A, Shannon B ( 1976 The influence of childbirth on psychiatric morbidity. Psychol Med 6:297 —302Google Scholar
  79. Krokowsky E (1974) Radiologie der Osteoporose. Therapiewoche 34: 3485 —3494Google Scholar
  80. Kronenberg F, Cote LJ, Linkie DM, Dyrenfurth I, Downey JA (1984) Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas 6: 3–43CrossRefGoogle Scholar
  81. Kuhl H, Taubert, H-D (1987) Das Klimakterium. Pathophysiologie, Klinik, Therapie. Thieme, StuttgartGoogle Scholar
  82. Lam SY, Baker HWG, Seeman E, Pepperell RJ (1988) Gynaecological disorders and risk factors in premenopausal women predisposing to osteoporosis: a review. Br J Obstet Gynaecol 95: 963–972PubMedCrossRefGoogle Scholar
  83. Lau EMC (1993) Hip fracture in Asia — trends, risk factors and prevention. In: Christiansen C, Riis B (eds) Proceedings 1993, Fourth International Symposium on Osteoporosis, Hong Kong. Aaalborg ApS, pp 58–61Google Scholar
  84. Laufer LR, Erlik Y, Meldrum DR, Judd HL (1982) Defect of clonidine on hot flashes in postmenopausal women. Obstet Gynecol 60: 583PubMedGoogle Scholar
  85. Lauritzen C (1975) Erfolge der hormonalen Therapie klimakterischer Beschwerden. Dtsch Ärzteblatt 9: 575–580Google Scholar
  86. Lauritzen C (1978) Management of the patient at risk. Front Horm Res 5: 230–247Google Scholar
  87. Lauritzen C (1980) Climacteric and obesity. I. Int Congress on Menopause and Obesity. RomeGoogle Scholar
  88. Lauritzen C (1982) Treatment of menopausal symptons with low doses of clonidine. Dtsch Med Wochenschr 107 /9, 335–338PubMedCrossRefGoogle Scholar
  89. Lauritzen C (1987) Transdermal delivery of 17ß-estradiol. In: Lauritzen C (ed) Transdermal estrogen substitution. Huber, Bern, pp 82–83Google Scholar
  90. Lauritzen C (1990a) Praktische Empfehlungen zur Östrogenprophylaxe in der Prä- und Postmenopause. Gynäkol Praxis 14:679— 688Google Scholar
  91. Lauritzen C (1990b) Nichthormonale Therapie klimakterischer Beschwerden. Gynäkol Praxis 14: 43–56Google Scholar
  92. Lievertz RW (1987) Pharmacology and pharmakinetics of estrogens. Am J Obstet Gynecol 156: 1289–1293PubMedGoogle Scholar
  93. Lind T, Cameron EC, Hunter WM et al (1979) A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol [Suppl 3] 86:1— 29Google Scholar
  94. Lindsay R, Tohme JF (1990) Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76: 290–295PubMedGoogle Scholar
  95. Lindsay R, Cosman F (1991) The risk of osteoporosis in aging women. In: Sitruk-Ware R, Utian WH (1991) The menopause and hormonal replacement therapy. Marcel Dekker, New York Basel Hong Kong, pp 47–72Google Scholar
  96. Lobo RA (1990) Cardiovascular implications of estrogen re- placement therapy. Obstet Gynecol 75 [Suppl]: 18–25Google Scholar
  97. Luine VN, Khylchevskaya RI, McEwen B (1975) Effect of gonodal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 86:293 — 306Google Scholar
  98. Marks R, Shahrad P (1976) Ageing and the effect of estrogen on the skin. In: Beard RS (ed) Menopause. MTP, Lancastert, pp 143–161Google Scholar
  99. Marks R, Shahrad P (1977) Skin changes at the time of the climacteric. In: Greenblatt RBB, Studd J (ed) Clinics in Obstetrics and Gynaecology 4. Saunders, London, p 207Google Scholar
  100. Marsh MS, Whitehead MI (1992) Managment of the menopause. Br Med Bull, vol 48: 426–458PubMedGoogle Scholar
  101. Mattingly RF, Huang WY (1969) Steroidogenesis of the menopausal and postmenopausal ovary. Am J Obstet Gynecol 103:679 — 693Google Scholar
  102. Mattson LA, Cullberg G, Samsioe G (1982) Evaluation of a continous oestrogen-progesteron regimen for climacteric complaints. Maturitas 4: 95–102CrossRefGoogle Scholar
  103. Mc Broon JR, Hayes WC, Edwards WT, Goldberg RP, White III AA (1985) Prediction of vertebral body compression fracture using quantitative computed tomography. J Bone Joint Surg 67: 1206–1214Google Scholar
  104. McEwen BS, Biegon A, Fischette CT, Luine VN, Parsons B, Rainbow TC (1984) Towards a neurochemical basis of steroid hormone action. In: Martini L, Ganong W (eds) Frontiers in neuroendocrinology. Raven, New York, pp 1153–1176Google Scholar
  105. McEwen BS (1991) Steroid hormones are multifunctional mes- sengers to the brain. Trends Endocrinol Metab 2: 62–67PubMedCrossRefGoogle Scholar
  106. McGregor GA, Best FE, Cam JM et al (1982) Double-blind randomized cross-over trial of moderate sodium restriction in essential hypertension. Lancet 1: 351CrossRefGoogle Scholar
  107. Meema S, Meema HE (1976) Menopausal bone loss and estrogen replacement. Isr J Med Sci 12: 601–604PubMedGoogle Scholar
  108. Melchert F (1987) Comparative clinical study of Estraderm TTS and Presomen (Premarin) in patients with postmenopausal syndrome. 5th International Congress on the Menopause, Sorrent, April 6–10, Panthenon Publishing, Sorrent, Abstr. 98; p 120Google Scholar
  109. Minne HW, Leidig G, Wüster CHR et al (1988) A newly developed spine deformity index ( SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone Miner 3: 335–349Google Scholar
  110. Meuwissen JHJM, van Langen H, Nielen M (1992) Endometriumwachstum während kontinuierlicher, alleiniger Östrogensubstitutionstherapie mit Estraderm TTS (0,05 mg/die) bei 31 postmenopausalen Frauen. Geburtshilfe Frauenheilkd 52:351— 354Google Scholar
  111. Muck AO (1990) Transdermales Therapeutisches System zur physiologischen Östrogensubstitution. Therapiewoche 40:41— 51Google Scholar
  112. Muck AO, Weber E, Blümner EG, Lippert TH (1994) Transdermale Östrogensubstitution — eine multizentrische Studie mit 15194 Patienten. Münchner Med Wochenschr 136:35 —40Google Scholar
  113. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckmann EM (1979) Estrogen replacement therapy. I. 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 53:277 — 281Google Scholar
  114. Nachtigall LE, Nachtigall NJ, Smilen SW, Nachtigall RH, Nachtigall RH (1993) Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement. (Vortrag 7. Weltkongress Menopause, Stockholm, Schweden) Abstr # 9, p 8Google Scholar
  115. Neugarten BL, Krainer RJ (1965) Menopausal symptoms in women of various ages. Psychosom Med 27:266–273 Nordin BEC (1980) The prevention of postmenopausal osteoporosis. Eur J Clin Invest 10 /4: 259–260Google Scholar
  116. Osmers R, Völksen M, Rath W, Teichmann A, Kuhn W (1989) Vaginosonographische Messungen des postmenopausalen Endometriums zur Früherkennung des Endometriumkarzinoms Geburtshilfe Frauenheilkd 49: 262–265sCrossRefGoogle Scholar
  117. Ott SM, Chesnut III CH (1987) Calcitriol treatment in patients with postmenopausal osteoporosis. In: Christiansen C, Johansen JS, Riis BJ (ed) Osteoporosis. Proceedings of the International Symposium on Osteoporosis, September 27-October 2, 1987. Osteopress 2: 844–849Google Scholar
  118. Ott SM, Kilnoyne RF, Chesnut CH (1987) Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women. J Bone Miner Res 2:201— 210Google Scholar
  119. Owen EJ, Siddle NC, McGarrigle T, Pugh MA (1989) Choosing the optimum dose of oestradiol implant — pharmacokinetics and symptom relief with 25 mg oestradiol implantation. Br Soc Obstet Gynaecol, LondonGoogle Scholar
  120. Paffenberger RS, Wing AL, Hyde RT, Jung DL (1983). Physical activity and incidence of hypertension in college alumni. Am J Epidemiol, 117: 245–257.Google Scholar
  121. Paterson MEL, Wade-Evans T, Sturdee DW, Thom MH, Studd JWW (1980) Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J I:822 — 824Google Scholar
  122. Plouffe L, Nolan JR TE, Speroff L, Lorrain J (1993) Continuing medical care of the menopausal woman In: Lorrain J, Plouffe L, Ravnikar Jr V, Speroff L, Watts N (eds) Comprehensive management of menopause, p 384Google Scholar
  123. Possinger K, Classen S, Beykirch M, Flath B, Wilmanns W (1991) Hormontherapie beim metastasierten Mammakarzinom der Frau. Dtsch Med Wochenschr 116: 1921–1929PubMedCrossRefGoogle Scholar
  124. Powers MS, Schenkel L, Darley PE, Good WR, Balestra JC (1985) Pharmakokinetics and pharmacodynamics of trans-dermal dosage forms of 17ß-estradiol: comparison with conventional oral estrogens used for hormone replacement. Am J Obstet Gynecol 152: 1099–1106PubMedGoogle Scholar
  125. Rabe TH (1990) Gynäkologie und Geburtshilfe. Ed. Medizin, VHC, WeinheimGoogle Scholar
  126. Rauramo L, Punnonen R (1973). Die Wirkung von Kastration und oraler Östrogentherapie auf die Haut der Frau. In: van Keep PA, Lauritzen C (Hrsg) Älter werden und Östrogene. Karger, Basel, S 51Google Scholar
  127. Recker RR (1993) Skeletal physiology: growth and aging. In: Lorrain J, Plouffe L, Ravnikar Jr V, Speroff L, Watts N (eds) Comprehensive management of menopause. pp 24Google Scholar
  128. Reginald PW, Adams J, Franks S, Wadsworth J, Beard RW (1989) Medroxyprogesterone acetate in the treatment of pelvic pain due to venous congestion. Br J Obstet Gynaecol 96: 1148PubMedCrossRefGoogle Scholar
  129. Reiners C (1991) Nicht-invasive quantitative Knochendichtebestimmung: In: Ringe JD (Hrsg) Osteoporose. de Gruyter, Berlin, S 157–216Google Scholar
  130. Riedel M, Rafflenbeul W (1992) Estrogens and cardiovascular diseases in postmenopausal women. Dtsch Med Wochenschr 117/31–32: 1205–1211Google Scholar
  131. Riggs BL, Hodgson S, O’Fallon W, Chao E, Wahner H, Muhs J, Cedel S, Melton LJ III (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322: 802–9PubMedCrossRefGoogle Scholar
  132. Riggs BL, O’Fallon W, Hodgson S, Chao E, Wahner H, Muhs J, Melton L (1992) Clinical trial of fluoride in osteoporotic women: extented observation and additional analyses.Google Scholar
  133. Ringe JD (1993) Indzidenz der Osteoporosefaktoren steigt weiter. Dtsch Ärztezeitung, S 14Google Scholar
  134. Rosemeier, Schultz-Zehden, pers. Mitteilung, 1993Google Scholar
  135. Rüegsegger P (1991) Einsatz der Knochendichtemessung in der Diagnostik und der Therapie der Osteoporose. Ther Umsch 48: 113–119PubMedGoogle Scholar
  136. Rüegsegger P, Durand EP, Dambacher MA (1991a) Differential effects of ageing and disease on trabecular and compact bone density of the radius. Bone 12: 99–105PubMedCrossRefGoogle Scholar
  137. Rüegsegger P, Durand E, Dambacher MA (1991b) Localisation of regional forearm bone loss from high resolution computed tomographic images. Osteoporosis Int 1:76 — 80Google Scholar
  138. Runnebaum B, Salbach B, von Holst Th (1994) Orale oder transdermale Östrogensubstitutionstherapie im Klimakterium? Geb Fra 54:119— 130Google Scholar
  139. Rylance PB, Brincat M, Lafferty K, De Trafford JC, Brincat S, Parsons V, Studd JWW (1985) Natural progesterone and antihypertensive action. Br Med J 290: 13CrossRefGoogle Scholar
  140. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Esiman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328: 1747–1752Google Scholar
  141. Schenkel L (1985) TTS-Estradiol zur physiologischen Hormonsubstitution in der Menopause. Schweiz Rundsch Med (Praxis) 74: 277–282Google Scholar
  142. Schiff I, Komarov Sela H, Cramer D, Tulchinsky D, Ryan KJ (1982) Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 37: 79–82PubMedGoogle Scholar
  143. Schneider HPG, Dören M (1993) Osteoporose aus gynäkologischer Sicht. Gynäkologe 26: 83–92PubMedGoogle Scholar
  144. Schneider P, Börner W (1990) Indikationen zur Knochendichtemessung und kritische Bewertung. Nuklearmediziner 13: 83–91Google Scholar
  145. Schneider P, Börner W (1991) Prediction of vertebral crush fractures in postmenopausal women with peripheral QCT in comparison to DEXA of the spine. Osteoporosis Int 1: 210 (abstract)Google Scholar
  146. Schneider P, Berger P, Moll E (1985) Getrennte Messung von Kompakta- und Spongiosadichte mit einem Transverdal-Rotations-Scanner. ROFO 143:178 —182Google Scholar
  147. Schneider P, Börner W, Mazess RB, Barden H (1988) The relationship of peripheral to axial bone density. Bone Miner 4:279— 87Google Scholar
  148. Schrage R (1985) Therapie des klimakterischen Syndroms. Edition Medizin, Weinheim, S 5–93Google Scholar
  149. Seibel MJ, Robins SP, Bilezikian JP (1992) Urinary pyridnium crosslinks of collagen. Specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 4:283 — 291Google Scholar
  150. Shangold MM (1983) Sports and exercise. In: Buchsbaum HJ (ed) The menopause. Springer, Berlin Heidelberg New York Tokyo, pp 199 — 203Google Scholar
  151. Sherman BM, West JH, Korenman SG (1976) The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42: 629–636Google Scholar
  152. Sherwin BB (1991a) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72: 336–343PubMedCrossRefGoogle Scholar
  153. Sherwin BB (1991b) Estrogen and Refractory Depression. Adv Neuropsychiatry Psychopharmacol 2:209 —218Google Scholar
  154. Smith P (1972) Age changes on the female urethra. Br J Urol 44: 667 — 676Google Scholar
  155. Staland B (1981) Continous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 3:145 —156Google Scholar
  156. Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence. Prey Med 20: 47–63CrossRefGoogle Scholar
  157. Stanczyk FZ, Shoupe D, Nunez V, Macias-Gonzales P, Vijod MA, Lobo RA (1988) A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol 159: 1540–1569PubMedGoogle Scholar
  158. Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265: 1985 —1990Google Scholar
  159. Stevenson JC, Abeyasekera G, Hillyard CJ, Phang KG, McIntyre I, Campbell S, Townsend PT, Young O, Whitehead MI (1981) Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet 1981/1:693 — 695Google Scholar
  160. Stevenson JC, White MC, Choplin GF, Macintyre I (1982) Osteoporosis and calcitonin deficiency. Br Med J 285: 1010–1015CrossRefGoogle Scholar
  161. Storm T, Thamsborg G, Steiniche T, Genant H, Sorensen OH (1990) Effect of intermittant cyclical etidronate on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322: 1265–71PubMedCrossRefGoogle Scholar
  162. Strecker JR (1990) Physiologische Abläufe im Klimakterium. In: Wolf AS, Schneider HPG (Hrsg) Östrogene in Diagnostik and Therapie. Springer, Berlin Heidelberg New York Tokyo, S 67 —76Google Scholar
  163. Strecker JR, Lauritzen C (1992) Praxis der Hormonbehandlung im Klimakterium. Enke, Stuttgart ( Bücherei des Frauenarztes, Bd 29 )Google Scholar
  164. Studd JWW, Collins WP, Chkavarti S, Newton JR, Oram D, Parson A (1977) Estradiol and testosterone implants in treatment of psychosexual problems in postmenopausal women. Br J Obstet Gynaecol 84: 314–315Google Scholar
  165. Sturdee DW, Wade-Evans T, Paterson MEL, Thom M, Studd JWW (1978) Relations between bleeding pattern, endometrial history, and oestrogen treatment in menopausal women. Br Med J L•1575–1577Google Scholar
  166. Sullivan JM, Vander Zwaag R, Hughes JP et al (1990) Estrogen replacement and coronary heart disease Arch Intern Med 150: 2557–62Google Scholar
  167. Taggart HM, Chesnut CH, Ivey JL, Baylink DJ, Sisom K, Huber HB, Roos BA (1985) Deficient calcitonin response to calcium stimulation in postmenopausal osteoporosis. Lancet I:475 — 480Google Scholar
  168. Teoh ES, Teoh LKK (1991) Improving the quality of life after 45. In: Teoh ES, Ratnam SS (eds) The future of gynaecology and obstetrics. Parthenon, Casterton Hall, Carnforth, Lancs., UKGoogle Scholar
  169. Thomas DB, Chu J (1986) Nutritional and endocrine factors in reproductive organ cancer: Opportunities for primary prevention. J Chron Dis 39: 1031–1050Google Scholar
  170. Tiegs RD, Body IJ, Wahner HW, Barta J, Riggs BL, Health III H (1985) Calcitonin secretion in postmenopausal osteoporosis. New Engl Med 312: 1097–1100CrossRefGoogle Scholar
  171. Tilyard MW, Spears GFS, Thompson J, Dovey S (1992) Treatment of osteoporosis with calcitriol or calcium. N Engl J Med 326: 357–62PubMedCrossRefGoogle Scholar
  172. Tulandi T, Lal S, Kinch RH (1983) Effect of intravenous clonidine on menopausal flashing and luteinizing hormone secretion. Br J Obstet Gynaecol 90: 854PubMedCrossRefGoogle Scholar
  173. Utian WH (1978) Effects of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. Maturitas 1: 3–8PubMedCrossRefGoogle Scholar
  174. van Keep PA, Greenblatt RB, Albeauch-Fernet M (eds) (1976) Consensus on menopause research. MTP Press, LancasterGoogle Scholar
  175. Vermeulen A (1976a) Postmenopausal ovarian function. In: James VHT, Serio M, Gusti G (Eds): The endocrine function of the human ovary. Academic Press, London New York San FranciscoGoogle Scholar
  176. Vermeulen A (1976b) The hormonal activity of the postmenopausal ovary. J Clin Endocr 42: 247–253PubMedCrossRefGoogle Scholar
  177. Vermeulen A (1980) Sex hormone status of the postmenopausal woman. Maturitas 3: 81–89CrossRefGoogle Scholar
  178. Voda AM (1981) Climacteric hot flash. Maturitas 3: 73–90PubMedCrossRefGoogle Scholar
  179. Von Stetten EC, Steiger P, Kelly L, Stein JA (1991) Paired a.p. and lateral spine dual x-ray absorptiometry improves precision of repeat lateral scans. J Bone Miner Res 6 [Supp11]: 171Google Scholar
  180. Warren MP, Brooks-Gunn J, Hamilton LH, Warren LF, Hamilton WG (1986) Scoliosis and fractures in young ballet dancers. Releation to delayed menarche and secondary amenorrhea. N Engl J Med 314: 1348–1353Google Scholar
  181. Wasnich RD, Ross PD, Heilbrun LK, Vogel JM (1985) Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol 153: 745–751PubMedGoogle Scholar
  182. Watts NB, Harris S, Genant HK et al (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323: 73–79PubMedCrossRefGoogle Scholar
  183. Weigel M, Schmitt W, Lieder H-J, Inthraphuvasak J (1990) Die Wertigkeit verschiedener Parameter zur sonographischen Beurteilung des postmenopausalen Endometriums hinsichtlich benigner und maligner Neoplasien. Geburtshilfe Frauenheilkd 50: 870–876PubMedCrossRefGoogle Scholar
  184. Winokur G (1973) Depression in the menopause. Am J Psychiatry 130: 92–93PubMedGoogle Scholar
  185. Whitehead MI (1986) Prevention of endometrial abnormalities. Acta Obstet Gynecol Scand [Suppl] 134: 81–91PubMedCrossRefGoogle Scholar
  186. Wüster CHR, Duckeck G, Ugurel A, Lojen M, Minne HW, Ziegler R (1990) Increased sensitivity of bone mass measurements by inclusion of body height and surface. In: Christiansen C, Overgaard K (eds) Osteoporosis, Osteopress ApS, Copenhagen, pp 623–625Google Scholar
  187. Wüster CHR, Schurr W, Scharla S, Raue F, Minne HW, Ziegler R (1991) Superior tolerability of human versus salmon calcitonin preparations in young healthy volunteers. J Eur Clin Pharmacol 41: 211–215CrossRefGoogle Scholar
  188. Wüster CHR, Duckeck G, Ugurel A, Lojen M, Minne HW, Ziegler R (1992) Bone mineral content of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters. Eur J Clin Invest 22: 366–370PubMedCrossRefGoogle Scholar
  189. Ziegler R (1982). Hormonale Behandlung und Prophylaxe der Osteoporose. In: HPG Schneider (Hrsg) Klimakerium der Frau. Seminar anläßlich des Kongresses für ärztliche Fortbildung, Berlin, 2. Juni 1982Google Scholar
  190. Zürcher Gesprächskreis (1994) Dt. Ärzteblatt 91: 11Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • B. Runnebaum
  • T. Rabe
  • T. v. Holst
  • C. Wüster

There are no affiliations available

Personalised recommendations